Our Services
Medical Information
Helpful Resources
Published on: 9/12/2026
Taking meloxicam with food or milk, using the lowest effective dose for the shortest time, and avoiding alcohol, smoking, and other NSAIDs like ibuprofen or aspirin can help reduce stomach pain and irritation. Doctors may also add a stomach-protecting medication such as a proton pump inhibitor for people at higher risk of ulcers or bleeding, including older adults and those on blood thinners or steroids. Several other factors matter too, including timing, hydration, kidney and heart health, and warning signs that mean you should stop the drug right away. See below to understand more before deciding what to change.
If stomach pain, nausea, black or bloody stools, or heartburn are showing up while you take meloxicam, it helps to know whether you are dealing with routine irritation or something that needs urgent care, and a free, instant, online symptom check can help you sort your symptoms and understand your next steps in just a few minutes.
Last reviewed for medical accuracy: 09/12/2026
Meloxicam is a widely prescribed nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation in conditions such as osteoarthritis and rheumatoid arthritis. While effective, it can cause gastrointestinal (GI) side effects—most commonly stomach pain, indigestion, ulcers, or bleeding. Below is a detailed, evidence-based guide on how to minimize these risks.
Patients at higher risk for ulcers or bleeding may benefit from:
Discuss with your physician whether adding one of these therapies is right for you.
Even with precautions, serious GI events can occur. Contact your doctor immediately if you notice:
For milder but lingering symptoms—such as ongoing indigestion, bloating, or mild discomfort—you may want to do a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Learn more with Ubie Symptom Checker
Always consult your healthcare provider if you experience any new or worsening symptoms. If stomach pain is severe or accompanied by signs of bleeding, immediate medical attention is essential. Never stop or adjust your dose of meloxicam without professional guidance.
Always remember: if you suspect a serious or life-threatening side effect, speak to a doctor immediately. Your health and safety come first.
(References)
* Noble S, Balfour JA. Meloxicam. Drugs. 1996 Mar;51(3):424-30; discussion 431-32. doi: 10.2165/00003495-199651030-00007. PMID: 8882380.
* Fleischmann R, Iqbal I, Slobodin G. Meloxicam. Expert Opin Pharmacother. 2002 Oct;3(10):1501-12. doi: 10.1517/14656566.3.10.1501. PMID: 12387696.
* Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, Sturkenboom M, Perez-Gutthann S, Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012 Dec 1;35(12):1127-46. doi: 10.2165/11633470-000000000-00000. PMID: 23137151; PMCID: PMC3714137.
* Khalil NY, Aldosari KF. Meloxicam. Profiles Drug Subst Excip Relat Methodol. 2020;45:159-197. doi: 10.1016/bs.podrm.2019.10.006. Epub 2019 Dec 12. PMID: 32164967.
* KuKanich K, George C, Roush JK, Sharp S, Farace G, Yerramilli M, Peterson S, Grauer GF. Effects of low-dose meloxicam in cats with chronic kidney disease. J Feline Med Surg. 2021 Feb;23(2):138-148. doi: 10.1177/1098612X20935750. Epub 2020 Jun 29. PMID: 32594827; PMCID: PMC10741344.
* Antiorio AT, Alemán-Laporte J, Zanatto DA, Pereira MAA, Gomes MS, Wadt D, Yamamoto PK, Bernardi MM, Mori CM. Mouse Behavior in the Open-field Test after Meloxicam Administration. J Am Assoc Lab Anim Sci. 2022 May 1;61(3):270-274. doi: 10.30802/AALAS-JAALAS-21-000046. Epub 2022 Jan 31. PMID: 35101160; PMCID: PMC9137284.
* Shavlovskaya OA, Bokova IA, Shavlovskiy NI. [Meloxicam clinical effects]. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(1):36-42. doi: 10.17116/jnevro202212201136. PMID: 35175701.
* Ziesenitz VC, Welzel T, van Dyk M, Saur P, Gorenflo M, van den Anker JN. Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years. Paediatr Drugs. 2022 Nov;24(6):603-655. doi: 10.1007/s40272-022-00514-1. Epub 2022 Sep 2. PMID: 36053397; PMCID: PMC9592650.
* Liu X, Zhao Y, Yang M, Ren J, Ouyang W, Wang S, Shen Y, Gao Y, Zhao L, Qin Z, Cao J, Xia J, Zhou H, Zeng H, Li J, Li Q, Jiang H, Zhou R, Yuan K, Jin S, Zhang X, Wang C, Chen Y, Dong H, Lv J, Yu S, Jiu Y, Wang Q, Su D, Yu W. Efficacy and safety of 4-hydroxy 2-methyl-N-(5-methyl-2-thiazolyl)-2H-1, 2-benzothiazin-3-carboxamide 1,1-dioxide, a fast-acting meloxicam formulation, on moderate-to-severe pain following abdominal surgery: A phase III randomized controlled trial. Clin Transl Sci. 2024 Dec;17(12):e70081. doi: 10.1111/cts.70081. PMID: 39660482; PMCID: PMC11632392.
* Tawfik AG, Gomez-Lumbreras A, Del Fiol G, Kawamoto K, Trinkley KE, Reese T, Jones A, Malone DC. Nonsteroidal Anti-Inflammatory Drugs and Risk of Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. Clin Pharmacol Ther. 2026 Jan;119(1):46-62. doi: 10.1002/cpt.70054. Epub 2025 Sep 7. PMID: 40915652; PMCID: PMC12746519.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.